Continuity Grant Support for Autologous Stem-Cell Based Tissue Engineered Treatment for Bronchopleural Fistula
Lead Participant:
VIDEREGEN LIMITED
Abstract
no public description
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| VIDEREGEN LIMITED | £249,000 | £ 249,000 |
Participant |
||
| INNOVATE UK |
People |
ORCID iD |
| Paul Armitage (Project Manager) |